Notice for ripretinib (Tudorrose Consulting Pty Ltd)
Active ingredients
ripretinib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet
Indication
For the treatment of gastrointestinal stromal tumours (GIST)
Therapeutic area
Oncology